Literature DB >> 6677877

Pediatric dosing of acetaminophen.

A R Temple.   

Abstract

Acetaminophen (paracetamol, APAP) is one of the safest and most widely used analgesic-antipyretics in children. When compared to other analgesic-antipyretics, acetaminophen has been shown in many clinical studies to have equivalent efficacy. Based on available clinical and pharmacokinetic data, acetaminophen should be dosed with single doses in the range of 10-15 mg/kg at 4-hour intervals. However, many dosing schedules recommend inadequate amounts of acetaminophen. Dosing schedules based on weight can be constructed that will accurately keep each dose within the recommended range. Dosing also can be adapted to an age-based schedule, which will provide consistent dosing from infancy to adolescence. The principles used to derive the age-based dosing schedule have potential application for use with other pharmacologic agents, particularly nonprescription drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6677877

Source DB:  PubMed          Journal:  Pediatr Pharmacol (New York)        ISSN: 0270-322X


  4 in total

1.  Comparison of the Efficacy and Safety of 2 Acetaminophen Dosing Regimens in Febrile Infants and Children: A Report on 3 Legacy Studies.

Authors:  Anthony R Temple; Brenda Zimmerman; Cathy Gelotte; Edwin K Kuffner
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jan-Feb

Review 2.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

Review 3.  Pharmacokinetics of common analgesics, anti-inflammatories and antipyretics in children.

Authors:  P D Walson; M E Mortensen
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

4.  An assessment of parents' knowledge and awareness regarding paracetamol use in children: a cross-sectional study from Palestine.

Authors:  Aiman Daifallah; Ruba Jabr; Faraj Al-Tawil; Moutaz Elkourdi; Ziad Salman; Amer Koni; Ahmad Samara; Samah W Al-Jabi; Sa'ed H Zyoud
Journal:  BMC Public Health       Date:  2021-02-18       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.